Zenith Laboratories

Zenith Laboratories was a prominent American pharmaceutical company specializing in the development, manufacturing, and marketing of generic prescription drugs. Based in Northvale, New Jersey, the company established a significant portfolio of multi-source pharmaceutical products across various therapeutic categories, including cardiovascular, anti-infective, and central nervous system disorders. Zenith was a publicly traded entity on the NASDAQ exchange under the symbol ZENI and was recognized as a leader in the early generic drug industry. In 1994, the company was acquired by IVAX Corporation in a transaction valued at approximately $600 million, which consolidated its position in the global generics market. Following the merger, Zenith's operations were integrated into IVAX's Goldline Laboratories division, and eventually became part of Teva Pharmaceutical Industries following Teva's acquisition of IVAX in 2006.